According to a new report by Polaris Market Research, the global Spine Biologics market was valued at USD 3.46 Billion in 2025 and is projected to reach USD 5.17 Billion by 2034, expanding at a CAGR of 4.55% over the forecast period. Growth is underpinned by the rising prevalence of spinal disorders, increasing surgical procedure volumes, growing adoption of minimally invasive spine...